JNJ vs CI
By Alex · Tickerpine
Johnson & Johnson vs The Cigna Group, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | CI |
|---|---|---|
| Price | $254.66 | $282.79 |
| Market cap | $613.02B | $74.81B |
| P/E ratio | 29.5 | 12.0 |
| ROE | 26.42% | 16.27% |
| Profit margin | 21.83% | 2.26% |
| Revenue growth | 9.90% | 4.60% |
| Dividend yield | 2.10% | 2.21% |
| Beta | 0.26 | 0.30 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs CI in plain English
- JNJ is the bigger company — about 8.2× the market cap of CI.
- CI is cheaper on earnings (P/E 12.0 vs 29.5).
- JNJ earns a higher return on equity (26% vs 16%).
- JNJ is growing revenue faster (10% vs 5%).
- CI has the higher dividend yield (2.21% vs 2.10%).
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
CI return calculator
See what $1,000 in The Cigna Group would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.